VENABLE LLP for AMERICAN ASSOCIATION OF PSYCHIATRIC PHARMACISTS
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Increasing access to mental health and substance use treatment, including via telehealth; Mental health & substance use disorder workforce; Federal funding for mental health and substance use programs, research and training; Preventing and reducing suicide; Medicare Part B coverage of pharmacist provided patient care services; Maintaining access to vaccines for children and adults; Medicare quality measures for and staffing of long-term care and skilled nursing facilities; Increase access to methadone for treatment of substance use; Maintain the six protected drug classes in Medicare Part D; Limiting the use of AI in health care decision making.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURA A HANEN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.